Purdue Pharma and Sackler Family Agree to $7.4 Billion Opioid Settlement

The deal, which includes significant funds for victims and relinquishment of company ownership, awaits court approval.

The Sackler family and Purdue Pharma will pay up to $7.4 billion, including $6.5 billion from the Sacklers, to resolve lawsuits over the opioid crisis.
The settlement includes $800-$850 million earmarked for direct compensation to victims and their families, a provision absent in the previous deal.
As part of the agreement, the Sacklers will relinquish ownership of Purdue Pharma, which will be restructured under a new entity governed by states and other plaintiffs.
The deal replaces a prior settlement blocked by the Supreme Court and limits legal protections for the Sacklers to entities participating in the agreement.
While hailed as a major step toward accountability, the settlement also includes a controversial $800 million legal defense fund for the Sacklers against future lawsuits.